The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain

Joseph V. Pergolizzi, Robert Taylor, Robert B. Raffa

Research output: Contribution to journalArticlepeer-review

Abstract

Acute pain, prevalent as part of postoperative and traumatic pain, is often sub-optimally or inadequately treated. Fixed-dose combination analgesic products that combine a reduced amount of opioid with a nonopioid analgesic such as acetaminophen (paracetamol) in a single tablet offer potential pharmacodynamic and/or pharmacokinetic benefits, and may also result in an opioid-sparing effect. A new analgesic product (XARTEMIS™ XR, Mallinckrodt Brand Pharmaceuticals, Dublin, Ireland) combines oxycodone (7.5 mg) with acetaminophen (325 mg) in an immediate-release/extended-release (ER) formulation that is indicated for the treatment of acute pain. The ER formulation of this product provides stable serum drug concentrations that in this case lasts 12 h. Oxycodone/acetaminophen is a drug combination that offers safe and effective pain relief in a variety of acute pain syndromes such as postoperative pain. The combination formulation allows a smaller amount of oxycodone per tablet and the biphasic-layered matrix of the pill for ER may present obstacles to potential abusers. No opioid is totally abuse resistant, but the lower opioid content and tamper-resistant formulation of this product might discourage abuse. Clinicians must still be mindful of the acetaminophen part of this product in the patient’s overall daily intake (in light of acetaminophen hepatotoxicity). The new product appears to provide an important new choice in the armamentarium against acute pain.

Original languageEnglish (US)
Pages (from-to)485-495
Number of pages11
JournalAdvances in Therapy
Volume32
Issue number6
DOIs
StatePublished - May 31 2015

Keywords

  • Acute pain control
  • Extended-release analgesics
  • Fixed-dose combination products
  • Oxycodone/acetaminophen (paracetamol)
  • Postoperative pain
  • Xartemis<sup>®</sup> XR

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Medicine(all)

Fingerprint Dive into the research topics of 'The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain'. Together they form a unique fingerprint.

Cite this